See All Slides - tctmd.com

Slides

Presentation TCT 2014

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients undergoing primary percutaneous coronary intervention: 3 Year___

Presenter: Georgios Vlachojannis

September 16, 2014

Presentation TCT 2014

Prognostic Difference of Normal Versus High Presenting Blood Pressure in Patients With Acute ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary___

Presenter: Donghun Shin

September 16, 2014

Presentation TCT 2014

The Cost of TAVR: Association Between Length of Stay and the Cost of Transfemoral Transcatheter Aortic Valve Replacement in Medicare Patients

Presenter: Christopher Meduri

September 16, 2014

Presentation TCT 2014

Multi-Vessel Versus Single-Vessel Treatment with Resolute Zotarolimus Eluting Stent in the RESOLUTE Global Clinical Program

Presenter: Ganesh Manoharan

September 16, 2014

Presentation TCT 2014

Assessment of Biocompatibility of the Multilayer Flow Modulator with Varying Thread Numbers

Presenter: Edel Kavanagh

September 16, 2014

Presentation TCT 2014

A New Thin-Strut, Low-Dose, Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating: Safety and Efficacy Clinical Performance of the Inspiron? Stent in___

Presenter: Guy F Prado Jr

September 16, 2014

Presentation TCT 2014

Management of very elderly patients with ST elevation myocardial infarction

Presenter: Usha Rao

September 16, 2014

Presentation TCT 2014

Detection of Paclitaxel Contamination Resulting from the Simulated Clinical Use of Drug Coated Balloon Catheters

Presenter: Charisse Ward

September 16, 2014

Presentation TCT 2014

Prediction of the True Fractional Flow Reserve of Left Main Coronary Artery Stenosis with Concomitant Downstream Stenoses: in vitro and in vivo Experiments_

Presenter: Erika Yamamoto

September 16, 2014

Presentation TCT 2014

The Clinical SYNTAX score has an additive predictive value in high risk patients

Presenter: Jeehoon Kang

September 16, 2014

Advertisement

Slides

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients undergoing primary percutaneous coronary intervention: 3 Year___

Prognostic Difference of Normal Versus High Presenting Blood Pressure in Patients With Acute ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary___

The Cost of TAVR: Association Between Length of Stay and the Cost of Transfemoral Transcatheter Aortic Valve Replacement in Medicare Patients

Multi-Vessel Versus Single-Vessel Treatment with Resolute Zotarolimus Eluting Stent in the RESOLUTE Global Clinical Program

Assessment of Biocompatibility of the Multilayer Flow Modulator with Varying Thread Numbers

A New Thin-Strut, Low-Dose, Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating: Safety and Efficacy Clinical Performance of the Inspiron? Stent in___

Management of very elderly patients with ST elevation myocardial infarction

Detection of Paclitaxel Contamination Resulting from the Simulated Clinical Use of Drug Coated Balloon Catheters

Prediction of the True Fractional Flow Reserve of Left Main Coronary Artery Stenosis with Concomitant Downstream Stenoses: in vitro and in vivo Experiments_

The Clinical SYNTAX score has an additive predictive value in high risk patients

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content